Cardinal Health CEO Jason M. Hollar sold 21,407 shares on 2026-08-18 at $234.56 per share, a transaction worth about $5.02 million. Because the filing is not marked as a pre-scheduled 10b5-1 trading plan (a plan that sets trades in advance), investors may view the timing as potentially more informative than an automatic sale. At the same time, insider sales can happen for many routine reasons such as taxes, diversification, or personal liquidity needs. The trade matters because it comes from the company’s top executive, who typically has the broadest view of operations and strategy. That said, this sale did not occur in isolation. It was part of a same-day cluster of sales by multiple Cardinal Health executives, including Stephen M. Mason ($727K), Deborah Weitzman ($1.57M), Jessica L. Mayer ($915K), and Michelle D. Greene ($586K). Clusters can reflect coordinated windows for trading (for example, after an earnings release or other disclosure) rather than a single executive acting on a unique view. Over the last 30 days, the reported insider activity at CAH has been exclusively selling, with all listed transactions occurring on 2026-08-18. Retail investors often look at whether selling is broad-based and whether it repeats over time; for now, the pattern appears concentrated in one day.